Does SONIDEGIB Cause Malignant neoplasm progression? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Malignant neoplasm progression have been filed in association with SONIDEGIB (Odomzo). This represents 2.3% of all adverse event reports for SONIDEGIB.
32
Reports of Malignant neoplasm progression with SONIDEGIB
2.3%
of all SONIDEGIB reports
8
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From SONIDEGIB?
Of the 32 reports, 8 (25.0%) resulted in death, 5 (15.6%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SONIDEGIB. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does SONIDEGIB Cause?
Muscle spasms (182)
Alopecia (107)
Off label use (100)
Fatigue (94)
Death (87)
Product use issue (70)
Nausea (69)
Product dose omission issue (66)
Therapy cessation (64)
Ageusia (59)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which SONIDEGIB Alternatives Have Lower Malignant neoplasm progression Risk?
SONIDEGIB vs SORAFENIB
SONIDEGIB vs SORGHUM HALEPENSE POLLEN
SONIDEGIB vs SOTAGLIFLOZIN
SONIDEGIB vs SOTALOL
SONIDEGIB vs SOTATERCEPT